
1. sci rep. 2017 jun 20;7(1):3881. doi: 10.1038/s41598-017-03984-3.

generating conditional gene knockouts plasmodium - toolkit produce stable
dicre recombinase-expressing parasite lines using crispr/cas9.

knuepfer e(1), napiorkowska m(2)(3), van ooij c(4), holder aa(5).

author information: 
(1)malaria parasitology laboratory, francis crick institute, 1 midland road, 
london, nw1 1at, united kingdom. ellen.knuepfer@crick.ac.uk.
(2)malaria biochemistry laboratory, francis crick institute, 1 midland road, 
london, nw1 1at, united kingdom.
(3)department biosystems science engineering, eth zurich, mattenstrasse
26, basel, 4058, switzerland.
(4)malaria biochemistry laboratory, francis crick institute, 1 midland road, 
london, nw1 1at, united kingdom. christiaan.vanooij@crick.ac.uk.
(5)malaria parasitology laboratory, francis crick institute, 1 midland road, 
london, nw1 1at, united kingdom. tony.holder@crick.ac.uk.

successful establishment crispr/cas9 genome editing technology plasmodium
spp. provided powerful tool transform plasmodium falciparum a
genetically tractable organism. conditional gene regulation approaches are
required study function gene products critical growth and
erythrocyte invasion blood stage parasites. employ crispr/cas9 to
facilitate use dimerisable cre-recombinase (dicre) frequently used
to mediate excision loss loxp-flanked dna sequences rapamycin
controlled manner. describe novel crispr/cas9 transfection plasmids and
approaches speedy, stable marker-free introduction transgenes
encoding dicre recombinase genomic loci dispensable blood stage
development. together plasmids form toolkit allow rapid
generation transgenic dicre-expressing p. falciparum lines genetic
background. furthermore, newly developed 3d7-derived parasite lines,
constitutively stably expressing dicre, generated using toolkit will
prove useful analysis gene products. lastly, introduce improved 
treatment protocol uses lower rapamycin concentration shorter
treatment times, leading loxp-guided recombination close 100%
efficiency within replication cycle.

doi: 10.1038/s41598-017-03984-3 
pmcid: pmc5478596
pmid: 28634346  [indexed medline]

